drugset / Trial / NCT05492591
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy, optimal dose and efficacy trend of multiple subcutaneous injections of peginterferon α1b in patients with herpes zoster, and provide support for phase III clinical trials.
Timeline
- Start
- 2022-10-11
- Primary completion
- 2023-07-22
- Completion
- 2023-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon α1b | Unknown | 5 ug/kg | Subcutaneous |
| Subject | Peginterferon α1b | Unknown | 6 ug/kg | Subcutaneous |
| Subject | Peginterferon α1b | Unknown | 7 ug/kg | Subcutaneous |
| Comparator | Valacyclovir | Unknown | — | — |